Verge Labs Introduces AI Model to Improve Patient Stratification in Neurology Trials
Verge Labs has developed a novel AI solution aimed at enhancing patient stratification in neurology clinical trials, potentially reducing trial failures.
Editorial Staff
1 min read
Updated 1 day ago
On June 16, 2026, Verge Labs announced the launch of a new AI model designed to address challenges in patient stratification for neurology clinical trials.
This innovative solution seeks to improve the efficiency of clinical trials by ensuring that the right patients are selected, which may help in reducing the high rates of trial failures.
The development of this AI model reflects a growing trend in the integration of artificial intelligence within the healthcare sector, particularly in the field of neurology.